Competitor Analysis: Interleukin-17/Receptor (IL-17/R) Antagonists
Competitor Analysis: Interleukin-17/Receptor (IL-17/R) Antagonists
The Competitive Intelligence report about Interleukin-17 (IL-17) inhibitors and IL-17 receptor IL-17R) antagonists provides a competitor analysis as of August 2015 in the development pipeline of novel inhibitors and antagonists of IL-17 and IL17R, respectively, for treatment of autoimmune and inflammatory diseases. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides a compilation of active small molecule projects in research and development as specific IL-17/R antagonists as well as dual target IL/17R inhibitorss for treatment of immunologic diseases. Competitor projects are listed in a tabular format providing information on:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
The Competitive Intelligence report about Interleukin-17 (IL-17) inhibitors and IL-17 receptor IL-17R) antagonists provides a competitor analysis as of August 2015 in the development pipeline of novel inhibitors and antagonists of IL-17 and IL17R, respectively, for treatment of autoimmune and inflammatory diseases. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.
The report provides a compilation of active small molecule projects in research and development as specific IL-17/R antagonists as well as dual target IL/17R inhibitorss for treatment of immunologic diseases. Competitor projects are listed in a tabular format providing information on:
- Drug Codes
- Target / Mechanism of Action
- Class of Compound
- Company
- Product Category
- Indication,
- R&D Stage and
additional comments with a hyperlink leading to the source of information.
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
1. COMPETITOR ANALYSIS: INTERLEUKIN-17/RECEPTOR (IL-17/R) ANTAGONISTS
Specific IL-17/R Antagonists
Dual Target IL-17/R Antagonists
2. CORPORATE IL-17/R ANTAGONIST R&D PORTFOLIOS
Specific IL-17/R Antagonists
Dual Target IL-17/R Antagonists
2. CORPORATE IL-17/R ANTAGONIST R&D PORTFOLIOS
